DIA: Driving Insights to Action
Science:Life Sciences
Durhane Wong-Rieger, President & CEO of the Canadian Organization for Rare Disorders speaks with Alberto Grignolo about patient involvement and engagement, and the future of drug development for rare diseases. Dr. Wong-Rieger is the first DIA Board Member to represent the voice of the patient.
view more
More Episodes
DIA/Tufts CSDD Research: AI Saving Time in Drug Development
2025-01-17
674
2025-01-17
674
DIA: Your Partner in Life Sciences Training and Development
2024-11-06
419
2024-11-06
419
GPP Experts Explain Authorship Algorithm
2024-04-23
304
2024-04-23
304
"Dossier in the Cloud" Democratizing Global Access
2024-04-02
340
2024-04-02
340
DIA: A Place Where You Can Make a Difference
2024-03-28
277
2024-03-28
277
Retiring TGA Head Maps Australia’s Post-Pandemic Future
2023-07-17
412
2023-07-17
412
Patient Engagement: Evolution of Who Knows What, Part 2
2023-06-14
308
2023-06-14
308
Patient Engagement: Evolution of Who Knows What, Part 1
2023-06-12
447
2023-06-12
447
Rwanda Welcomes African Medicines Agency Home
2022-11-30
617
2022-11-30
617
Will Technology Solve the Research “People Problem”?
2022-11-22
387
2022-11-22
387
Why Trans/Nonbinary Research Benefits All Communities
2022-11-18
814
2022-11-18
814
Digital Revolutionizing Data-Driven Reimbursement
2022-10-20
413
2022-10-20
413
China Sets New Record for Local Drug Approvals in 2021
2022-09-15
446
2022-09-15
446
WHO Pilot Formalizes CSA Process to Assist Developers
2022-08-02
444
2022-08-02
444
Get this podcast on your
phone, FREE
